SUTOL Bio · Drug Delivery Platform

The first gram-scale monthly
oral capsule.

One dose a month. No daily pills, no painful injections. Just continuous therapy from a single capsule you swallow.

Scroll
The Problem

Poor adherence is the #1 avoidable challenge in chronic disease.

It’s most visible in five major human conditions where strict, long-term therapy is required, yet where adherence consistently fails, and in companion animals, where every dose depends on an owner.

Human indications
Opioid Use DisorderSchizophreniaHIVAlcohol Use DisorderBipolar Disorder
Companion animal
Atopic Dermatitis
Today’s Options Fall Short

Between the two standards of care lies a clear white space.

01Adherence fails

Daily oral pills

Simple and familiar, but effective adherence is unrealistic without caregivers, and missed doses undermine therapy.

02Painful · irreversible

Long-acting injectables

Effective for adherence, but painful, prone to injection complications, and irreversible once administered.

A safe, patient-friendly, cost-effective, reversible, pharmacy-based oral solution that ensures adherence, all without the burdens of injections.

The Solution

One monthly dose.
30+ days of release.

The first gram-scale monthly oral capsule platform. It resides safely in the stomach and releases therapy continuously for over a month. It is reversible, pharmacy-based, and reimbursement-ready. The same platform carries our five human indications and a companion animal program in atopic dermatitis.

30+
Days of continuous release
1
Monthly oral dose
Gram
Scale drug payload
6
Pipeline indications
Our Foundation

Built in the Langer & Traverso labs at MIT.

SUTOL Bio was born from six years of translational research at MIT, combining decades of pioneering work in drug delivery with cutting-edge biomedical engineering to create transformative therapies for patients worldwide.

MIT
Origin
6 yrs
Translational research
Cambridge
Massachusetts HQ
Partner With SUTOL

Let’s advance the future of drug delivery.

We’re building the first gram-scale monthly oral capsule. Reach out about partnerships, research collaboration, or investment.

contact@sutolbio.com →